NICE publish consultation on revised proposal for HTA fees

NICE has published a consultation on its amended proposals to charge companies for making technology appraisals and recommendations. The consultation seeks views on the proposed charging policy and procedures, with the intention of introducing such charges with effect from 1 April 2019. In addition, NICE is also seeking views on a proposal to enable the recruitment of Appeal Panel members engaged in the provision of health care across the UK; currently it can only recruit members from England. The consultation is scheduled to close on 14 September 2018.

NICE fees for HTA’s

NICE is currently largely funded by taxpayers’ money through the Department of Health & Social Care (DHSC), although NICE’s Government funded budget, like that of other public bodies, is decreasing, from £66.4 million in 2013/14 to £51.2 million in 2018/19. As a result, NICE consulted on proposals for companies to cover the costs of HTA submissions in the autumn of 2016, the revised version of which is subject to the current consultation. As part of their revised proposals, NICE have reduced the charges for SME’s, defined under Section 382 of the Companies Act 2006, to 75% of the fees paid by larger companies, and have also allowed SME’s to pay in instalments:

Proposed charges for technology appraisals:

Product Larger companies proposed 2018/19 charges (ex VAT) Small companies proposed 2018/19 charges (ex VAT)
STA £126,000 £94,500
HST £126,000 £94,000
FTA/RR £88,000 £66,000
MTA- standard £188,000 £141,000
MTA- complex £251,000 £188,000

2016 Consultation proposed charges:

Product 2016 proposed fee (ex VAT)
STA £142,000
HST £142,000
FTA/RR £99,000
MTA – standard £210,000
MTA – complex £282,000

NICE appeal panel reforms

The Regulations currently require NICE to have processes in place to hear appeals against its technology appraisal and highly specialised technology recommendations. However, the appeal panel members are currently restricted to those engaged in the provision of health care in England; the revised proposals would widen the pool of potential candidates to health care workers across the United Kingdom.

Consultation Questions 

  1. Do you agree or disagree that charging companies for making technology appraisal and highly specialised technology recommendations provides a more sustainable model for this activity in the longer term, given the wider policy landscape, budgetary pressures and the need to be responsive to developments in the life sciences industry? Please explain your response, including any alternative proposals if you disagree.
  2. Do you agree or disagree that such charges should be calculated on a cost recovery basis? Please explain your response, including any alternative proposals if you disagree.
  3. Do you agree or disagree that small companies (as defined by the Companies Act) should pay 25% less for technology appraisal and highly specialised technology recommendations than larger companies? Please explain your response, including any alternative proposals if you disagree.
  4. Do you agree or disagree that small companies should be able to pay in instalments? Please explain your response, including any alternative proposals if you disagree.
  5. Do you agree or disagree with the analysis in the accompanying Impact Assessment on the impacts of the proposed charging? Please explain your response, including any alternative data or assumptions if you disagree.
  6. Do you agree or disagree that NICE’s appeal panel NHS membership should be drawn from the whole of the UK and not just England? Please explain your response.
  7. Do you have any further comments on the proposals in this consultation document?

The full consultation document can be found here. To respond to the consultation document, click here:

Tagged with

Published 9. August 2018 in News, News UK